Review of Evidence-Based Support for Pretreatment Imaging in Melanoma

When making a new diagnosis of melanoma, clinicians often obtain imaging studies to rule out clinically occult distant disease. These studies range from inexpensive tests, such as chest radiographs, to more expensive studies, such as PET/CT. The impetus for ordering these studies is usually the desire to identify potentially resectable distant disease, avoid surgery when curative resection is not possible, and assuage patient anxiety by showing that no evidence of distant disease is present. However, some detrimental aspects to these studies are less apparent, including cost and potential for false-positive findings. Although routine use seems reasonable, the true benefit of these studies depends on the probability of clinically occult disease being present, likelihood that disease will be detected with the available technology, and impact of earlier detection on outcome. Contrary to current practice patterns, available evidence suggests that preoperative imaging studies are associated with significant costs and minimal benefit in most patients with melanoma. This article reviews available literature on the role of pretreatment imaging in patients with newly diagnosed cutaneous melanoma.

If the inline PDF is not rendering correctly, you can download the PDF file here.

Correspondence to: Michael S. Sabel, MD, University of Michigan Health Systems, 1500 East Medical Center Drive, 3303 Cancer Geriatric Center SPC 5932, Ann Arbor, MI 48109-5932. E-mail: msabel@med.umich.eduDisclosure: Michael S. Sabel, MD, has disclosed no relevant financial relationships.Disclosure: Sandra L. Wong, MD, has disclosed no relevant financial relationships.Disclosure: Kerrin G. Robinson, MA, has disclosed no relevant financial relationships.
  • 1

    BalchCMSoongSJGershenwaldJE. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol2001;19:36223634.

    • Search Google Scholar
    • Export Citation
  • 2

    CoitDGAndtbackaRBichakjianCK. NCCN Clinical Practice Guidelines in Oncology: Melanoma version 2 2009. Available at: http://www.nccn.org/professionals/physician_gls/f_ guidelines.asp. Accessed January 12 2009.

    • Search Google Scholar
    • Export Citation
  • 3

    SoberAJChuangTYDuvicM. Guideline of care for primary cutaneous melanoma. J Am Acad Dermatol2001;45:579586.

  • 4

    RobertsDLLAnsteyAVBarlowRJ. U.K. guidelines for the management of cutaneous melanoma. Br J Dermatol2003;146:717.

  • 5

    HofmannUSzedlakMRittgenW. Primary staging and follow-up in melanoma patients: monocenter evaluation of methods, costs and patient survival. Br J Cancer2002;87:151157.

    • Search Google Scholar
    • Export Citation
  • 6

    WeissMLoprinziCLCreaganET. Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas. JAMA1995;274:17031705.

    • Search Google Scholar
    • Export Citation
  • 7

    LeiterUMeierFSchittekBGarbeC. The natural course of cutaneous melanoma. J Surg Oncol2004;86:172178.

  • 8

    PatelJKDidolkarMSPickrenJWMooreRH. Metastatic pattern of malignant melanoma. A study of 216 autopsy cases. Am J Surg1978;135:807810.

    • Search Google Scholar
    • Export Citation
  • 9

    KhansurTSandersJDasSK. Evaluation of staging workup in malignant melanoma. Arch Surg1989;124:847849.

  • 10

    ArdizzoniAGrimaldiARepettoL. Stage I-II melanoma: the value of metastatic work-up. Oncology1987;44:8789.

  • 11

    ZartmanGMThomasMRRobinsonWA. Metastatic disease in patients with newly diagnosed malignant melanoma. J Surg Oncol1987;35:163164.

  • 12

    YancowitzMFineltNWarychaMA. Role of radiologic imaging at the time of initial diagnosis of stage T1b-T3b melanoma. Cancer2007;110:11071113.

    • Search Google Scholar
    • Export Citation
  • 13

    HafnerJSchmidMHKempfW. Baseline staging in cutaneous malignant melanoma. Br J Dermatol2004;150:677686.

  • 14

    WangTSJohnsonTMCascadePN. Evaluation of staging chest radiographs and serum lactate dehydrogenase for localized melanoma. J Am Acad Dermatol2004;51:399405.

    • Search Google Scholar
    • Export Citation
  • 15

    TerhuneMHSwansonNJohnsonTM. Use of chest radiography in the initial evaluation of patients with localized melanoma. Arch Dermatol1998;134:569572.

    • Search Google Scholar
    • Export Citation
  • 16

    KanzlerMH. Initial evaluation of melanoma (letter to the editor). Arch Dermatol1999;135:11211122.

  • 17

    WeissMLoprinziCLCreaganET. Utility of follow-up tests for detecting recurrent disease in patients with malignant melanoma. JAMA1995;274:17031705.

    • Search Google Scholar
    • Export Citation
  • 18

    WebbWRGamsuG. Thoracic metastasis in malignant melanoma: a radiographic survey of 66 patients. Chest1977;71:176181.

  • 19

    ChenJTDahmashNSRavinCE. Metastatic melanoma to the thorax. AJR Am J Roentgenol1981;137:293298.

  • 20

    Das GuptaTBrasfieldR. Metastatic melanoma. Cancer1964;17:13231339.

  • 21

    GrossEA. Initial evaluation of melanoma: Don‘t stop getting that chest x-ray....yet. Arch Dermatol1998; 134:623624.

  • 22

    ParishLCWitkowskiJA. Melanoma and the radiograph: sanctity of human life. Lancet1998; 352:922923.

  • 23

    KleinMFreedmanNLotemM. Contribution of whole body F-18-FDG-PET and lymphoscintigraphy to the assessment of regional and distant metastases in cutaneous malignant melanoma. Nuklearmedizin2000;39:5661.

    • Search Google Scholar
    • Export Citation
  • 24

    BelhocineTPierardGDe LabrassinneM. Staging of regional nodes in AJCC stage I and II melanoma: 18FDG PET imaging versus sentinel node detection. Oncologist2002;7:271278.

    • Search Google Scholar
    • Export Citation
  • 25

    FinkAMHolle-RobatschSHerzogN. Positron emission tomography is not useful in detecting metastasis in the sentinel lymph node in patients with primary malignant melanoma stage I and II. Melanoma Res2004;14:141145.

    • Search Google Scholar
    • Export Citation
  • 26

    LongoMILazaroPBuenoC. Flourodeoxyglucose-positron emission tomography imaging versus sentinel node biopsy in the primary staging of melanoma patients. Dermatol Surg2003;29:245248.

    • Search Google Scholar
    • Export Citation
  • 27

    LibberechtKHusadaGPeetersT. Initial staging of malignant melanoma by positron emission tomography and sentinel node biopsy. Acta Chir Belg2005;105:621625.

    • Search Google Scholar
    • Export Citation
  • 28

    VereeckenPLaporteMPeteinM. Evaluation of extensive intitial staging procedure in intermediate/high-risk melanoma patients. J Eur Acad Dermatol Venereol2005;19:6673.

    • Search Google Scholar
    • Export Citation
  • 29

    ClarkPBSooVKraasJ. Futility of flourodeoxyglucose F18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma. Arch Surg2006;141:284288.

    • Search Google Scholar
    • Export Citation
  • 30

    KellMRRidgeJAJosephNSigurdsonER. PET CT imaging in patients undergoing sentinel node biopsy for melanoma. Eur J Surg Onc2007;33:911913.

    • Search Google Scholar
    • Export Citation
  • 31

    EssnerRBelhocineTScottAMEven-SapirE. Novel imaging techniques in melanoma. Surg Oncol Clin N Am2006;15:253283.

  • 32

    Ho ShonIAChungDKSawRPThompasonJF. Imaging in cutaneous melanoma. Nucl Med Commun2008;29:847876.

  • 33

    CrippaFLeutnerMBelliF. Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma. J Nucl Med2000;41:14911494.

    • Search Google Scholar
    • Export Citation
  • 34

    WagnerJDSchauweckerDDavidsonD. Inefficacy of F-18 flourodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma. Cancer2005;104:570579.

    • Search Google Scholar
    • Export Citation
  • 35

    AlvarezSAnorbeEAlcortaP. Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review. AJR Am J Roentgenol2006;186:13421348.

    • Search Google Scholar
    • Export Citation
  • 36

    RossiCRMocellinSScagnetB. The role of preoperative ultrasound scan in detecting lymph node metastasis before sentinel node biopsy in melanoma patients. J Surg Oncol2003;82:8084.

    • Search Google Scholar
    • Export Citation
  • 37

    VoitCKronMSchaferG. Ultrasound-guided fine needle aspiration cytology prior to sentinel lymph node biopsy in melanoma patients. Ann Surg Oncol2006;13:16821689.

    • Search Google Scholar
    • Export Citation
  • 38

    StarrittECUrenRFScolyerRA. Ultrasound examination of sentinel nodes in the initial assessment of patients with primary cutaneous melanoma. Ann Surg Oncol2005;12:1823.

    • Search Google Scholar
    • Export Citation
  • 39

    BuzaidACSandlerABManiS. Role of computed tomography in the staging of primary melanoma. J Clin Oncol1993;11:638643.

  • 40

    MortonDLThompsonJFCochranAJ. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med2006; 355:13071317.

  • 41

    StrobelKSkalskyJKalffV. Tumour assessment in advanced melanoma: value of FDG-PET/CT in patients with elevated serum S-100B. Eur J Nucl Med Mol Imaging2007;34:13661375.

    • Search Google Scholar
    • Export Citation
  • 42

    MirandaEPGertnerMWallJ. Routine imaging of asymptomatic melanoma patients with metastasis to sentinel lymph nodes rarely identifies systemic disease. Arch Surg2004;139:831837.

    • Search Google Scholar
    • Export Citation
  • 43

    ConstantinidouAHofmanMO’DohertyM. Routine positive emission tomography and positron emission tomography/computed tomography in melanoma staging with positive sentinel node biopsy is of limited benefit. Melanoma Res2008;18:5660.

    • Search Google Scholar
    • Export Citation
  • 44

    AloiaTAGershenwaldJEAndtbackaRH. Utility of computed tomography and magnetic resonance staging in patients with stage III melanoma diagnosed by sentinel lymphadenectomy. J Clin Oncol2006;24:28582865.

    • Search Google Scholar
    • Export Citation
  • 45

    GoldJSJaquesDPBusamKJ. Yield and predictors of radiologic studies for identifying distant metastases in melanoma patients with a positive sentinel lymph node biopsy. Ann Surg Oncol2007;14:21332140.

    • Search Google Scholar
    • Export Citation
  • 46

    KuvshinoffBWKurtzCCoitDG. Computed tomography in evaluation of patients with stage III melanoma. Ann Surg Oncol1997;4:252258.

  • 47

    BuzaidACTinocoLRossMI. Role of computed tomography in the staging of patients with local-regional metastases of melanoma. J Clin Oncol1995;13:21042108.

    • Search Google Scholar
    • Export Citation
  • 48

    JohnsonTMFaderDJChangAE. Computed tomography in staging of patients with melanoma metastatic to the regional nodes. Ann Surg Oncol1997;4:396402.

    • Search Google Scholar
    • Export Citation
  • 49

    TylerDSOnaitisMKheraniA. Positron emission tomography scanning in malignant melanoma. Clinical utility in patients with stage III disease. Cancer2000;89:10191025.

    • Search Google Scholar
    • Export Citation
  • 50

    DamianDLFulhamMJThompsonEThompsonJF. Positron emission tomography in the detection and management of metatatic melanoma. Melanoma Res1996;6:325329.

    • Search Google Scholar
    • Export Citation
  • 51

    BradyMSAkhurstTSpanknebelK. Utility of preoperative [(18)F flourodeoxyglucose-positron emission tomography scanning in high-risk melanoma patients. Ann Surg Oncol2006;13:525532.

    • Search Google Scholar
    • Export Citation
  • 52

    PfannenbergCAschoffPSchanzS. Propspective comparison of (18)F flouroudeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma. Eur J Cancer2007;43:557564.

    • Search Google Scholar
    • Export Citation
  • 53

    ReinhardtMJJoeAYJaegerU. Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients. J Clin Oncol2006;24:11781187.

    • Search Google Scholar
    • Export Citation
  • 54

    StrobelKDummerRHusarikDB. High risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases. Radiology2007;244:566574.

    • Search Google Scholar
    • Export Citation
  • 55

    HarrisMTBerlangieriSUCebonJS. Impact of 2-deoxy-2[F-18] fluoro-D-glucose postiron emission tomography on the management of patients with advanced melanoma. Mol Imaging Biol2005;7:304308.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 43 43 7
PDF Downloads 9 9 0
EPUB Downloads 0 0 0